Mirae Asset Global Investments Co. Ltd. Purchases 36,832 Shares of Humana Inc. $HUM

Key Points

• Mirae Asset Global Investments initiated a Humana position, purchasing 36,832 shares worth approximately $14.1 million in the third quarter.
• Institutional investors own 92.38% of Humana shares; several other firms also reported increasing or initiating holdings during the quarter.
• Humana declared a quarterly dividend of $0.885 per share, equivalent to $3.54 annually and a 0.8% yield. Analysts’ consensus rating was “Moderate Buy,” with a $453.30 average price target.

Mirae Asset Global Investments Co. Ltd. purchased a new position in Humana Inc. (NYSE:HUM - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 36,832 shares of the insurance provider's stock, valued at approximately $14,054,000.

Other hedge funds have also recently modified their holdings of the company. ProShare Advisors LLC increased its stake in shares of Humana by 1.9% during the third quarter. ProShare Advisors LLC now owns 19,489 shares of the insurance provider's stock valued at $7,436,000 after buying an additional 364 shares during the period. Vise Technologies Inc. raised its holdings in shares of Humana by 18.1% during the third quarter. Vise Technologies Inc. now owns 2,908 shares of the insurance provider's stock valued at $1,110,000 after acquiring an additional 445 shares in the last quarter. Cidel Asset Management Inc. lifted its stake in Humana by 1.3% in the third quarter. Cidel Asset Management Inc. now owns 3,935 shares of the insurance provider's stock worth $1,501,000 after acquiring an additional 52 shares during the period. MGO One Seven LLC boosted its holdings in Humana by 1.8% in the third quarter. MGO One Seven LLC now owns 3,467 shares of the insurance provider's stock valued at $1,323,000 after acquiring an additional 60 shares in the last quarter. Finally, Soltis Investment Advisors LLC bought a new stake in Humana in the third quarter valued at $471,000. Hedge funds and other institutional investors own 92.38% of the company's stock.

Humana Trading Up 1.8%

NYSE HUM opened at $417.70 on Wednesday. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $456.50. The firm has a market capitalization of $50.16 billion, a PE ratio of 39.52, a P/E/G ratio of 2.53 and a beta of 0.65. The stock's 50 day moving average is $402.16 and its 200 day moving average is $310.09.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Shareholders of record on Thursday, December 24th will be given a dividend of $0.8850 per share. The ex-dividend date of this dividend is Thursday, December 24th. This represents a $3.54 annualized dividend and a yield of 0.8%. Humana's dividend payout ratio (DPR) is currently 33.49%.

Analyst Ratings Changes

A number of research analysts have issued reports on HUM shares. Morgan Stanley raised shares of Humana from an "underweight" rating to an "overweight" rating in a research report on Friday, October 9th. TD Cowen raised their target price on shares of Humana from $350.00 to $370.00 and gave the stock a "hold" rating in a research report on Friday, July 31st. HSBC lowered shares of Humana to a "hold" rating in a research note on Thursday, July 30th. Zacks Research lowered shares of Humana from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, August 11th. Finally, Wolfe Research reiterated an "outperform" rating and set a $450.00 price target on shares of Humana in a research report on Monday, August 24th. Twenty-one investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $453.30.

Humana Company Profile

Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company's primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.

Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.

Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.